相关实验视频

Updated: Jan 11, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

素A在2型糖尿病中的演变作用及其潜在的临床影响:一篇综述

Mohammed Jemal¹, Nuredin Chura Waritu², Temesgen Baylie³

¹Department of Biomedical Science, School of Medicine, Debre Markos University, P.O. Box 269, Debre Markos, Ethiopia.

Therapeutic advances in chronic disease

|November 13, 2025

概括

与胰岛素抵抗和炎症相关的蛋白质Fetuin-A显示出作为2型糖尿病 (T2DM) 的诊断标记物的希望. 研究强调其在T2DM发展和并发症中的潜在作用,指导未来的治疗策略.

科学领域:

内分泌学在内分泌学.
代谢疾病代谢疾病
生物化学生物化学

背景情况:

2型糖尿病 (T2DM) 是一个日益严重的全球健康问题,其特点是胰岛素抵抗,胰岛素生产受损和慢性炎症.
在T2DM中血糖控制不良会导致严重的微血管 (脏病,视网膜病,神经病) 和大血管 (心血管疾病) 并发症.
确定可靠的诊断指标和新的治疗目标对于管理T2DM患病率及其不良结果至关重要.

研究的目的:

审查fetuin-A在T2DM及其相关并发症的发病过程中的作用.
探索fetuin-A作为T2DM的诊断生物标志物和治疗点的潜力.
讨论T2DM管理中关于 fetuin-A 的未来前景.

主要方法:

这项研究是对现有文献的叙述性审查.
它综合了从临床研究中调查与T2DM相关的fetuin-A水平的研究结果.
该审查重点关注fetuin-A.的生物功能和临床意义.

主要成果:

费图因-A,也称为α-2-Heremans Schmid糖蛋白,是一种肝脏分泌的糖蛋白,涉及胰岛素抵抗,代谢综合征和炎症.
循环中的Fetuin-A水平升高与T2DM及其并发症有显著关联.
费图因-A显示出作为T2DM的预测生物标志物和治疗点的潜力.

结论:

费图因-A在T2DM及其并发症的发展中起着重要作用.
循环中的fetuin-A水平是T2DM风险和进展的有价值指标.
对Fetuin-A的进一步研究可能会导致新型诊断工具和2型糖尿病治疗策略.

关键词:

生物标志物生物标志物临床影响临床影响胎儿 - 一个肝毒素 (hepatokine) 是一种肝毒素胰岛素耐药性是一种胰岛素耐药性.胰岛素的信号传递方式代谢性炎症是一种代谢性炎症.2型糖尿病是什么?

更多相关视频

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

相关概念视频

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

Carbohydrate Metabolism

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Diabetes: Symptoms, Diagnosis, and Complications

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...